StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73−0.05 (-2.81%)

Close on Nov 18, 2026Market cap $52.74MP/E –Yield –

XBiotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

XBiotech's free cash flow for the twelve months ending Jun 30, 2026 was -$40.84M. For fiscal 2025 it was -$40.21M. The highest annual figure on record is $65.92M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.21M–
FY2024Dec 31, 2024-$32.27M–
FY2023Dec 31, 2023-$19.09M–
FY2022Dec 31, 2022-$15.41M-123.4%
FY2021Dec 31, 2021$65.92M–
FY2020Dec 31, 2020-$68.88M–
FY2019Dec 31, 2019-$18.47M–
FY2018Dec 31, 2018-$16.66M–
FY2017Dec 31, 2017-$35.05M–
FY2016Dec 31, 2016-$50.76M–
FY2015Dec 31, 2015-$35.63M–
FY2014Dec 31, 2014-$13.10M–
FY2013Dec 31, 2013-$8.97M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.52M–
Q1 FY2026Mar 31, 2026-$8.97M–
Q4 FY2025Dec 31, 2025-$22.99M–
Q3 FY2025Sep 30, 2025-$4.37M–
Q2 FY2025Jun 30, 2025-$6.04M–
Q1 FY2025Mar 31, 2025-$6.81M–
Q4 FY2024Dec 31, 2024-$6.62M–
Q3 FY2024Sep 30, 2024-$6.18M–
Q2 FY2024Jun 30, 2024-$12.00M–
Q1 FY2024Mar 31, 2024-$7.46M–
Q4 FY2023Dec 31, 2023-$3.55M–
Q3 FY2023Sep 30, 2023-$1.52M–
Q2 FY2023Jun 30, 2023-$9.21M–
Q1 FY2023Mar 31, 2023-$4.81M–
Q4 FY2022Dec 31, 2022-$3.30M–
Q3 FY2022Sep 30, 2022-$1.36M–
Q2 FY2022Jun 30, 2022-$5.47M-107.7%
Q1 FY2022Mar 31, 2022-$5.28M-550.9%
Q4 FY2021Dec 31, 2021-$2.24M–
Q3 FY2021Sep 30, 2021-$4.10M-160.4%
Q2 FY2021Jun 30, 2021$71.09M–
Q1 FY2021Mar 31, 2021$1.17M–
Q4 FY2020Dec 31, 2020-$2.61M–
Q3 FY2020Sep 30, 2020$6.79M–
Q2 FY2020Jun 30, 2020-$11.99M–
Q1 FY2020Mar 31, 2020-$61.06M–
Q4 FY2019Dec 31, 2019-$3.75M–
Q3 FY2019Sep 30, 2019-$5.15M–
Q2 FY2019Jun 30, 2019-$4.89M–
Q1 FY2019Mar 31, 2019-$4.68M–
Q4 FY2018Dec 31, 2018-$5.12M–
Q3 FY2018Sep 30, 2018-$4.03M–
Q2 FY2018Jun 30, 2018-$3.95M–
Q1 FY2018Mar 31, 2018-$3.56M–
Q4 FY2017Dec 31, 2017-$7.06M–
Q3 FY2017Sep 30, 2017-$6.73M–
Q2 FY2017Jun 30, 2017-$8.75M–
Q1 FY2017Mar 31, 2017-$12.52M–
Q4 FY2016Dec 31, 2016-$13.33M–
Q3 FY2016Sep 30, 2016-$15.63M–

More XBiotech figures

See a number that looks wrong?